Northpond Ventures
Northpond Ventures is a science-driven venture capital firm dedicated to advancing science and technology for the benefit of humanity. The firm focuses on building and supporting breakthrough science and technology-driven businesses to create a marked impact on humanity. With a strong emphasis on collaboration with leading academic institutions, Northpond Ventures aims to translate scientific discoveries into viable businesses, particularly in the fields of biotechnology, diagnostics, digital health, and environmental solutions.
Northpond Ventures
What We Do
Northpond Labs provides capital to support early-stage science at leading academic institutions, enabling the translation of scientific discoveries from the lab to create companies ready for seed-stage funding.
Northpond Labs advises academic partners on the intricacies of the venture process, fostering an entrepreneurial culture to advance scientific discoveries.
Northpond Labs collaborates with scientists and entrepreneurs to translate scientific discoveries into commercial opportunities, providing strategic guidance and support.
Northpond Builds assists in negotiating intellectual property licenses from academic institutions to facilitate company formation.
Northpond Builds provides support in developing product and pipeline strategies for emerging companies.
Northpond Builds supports the formation of companies by providing direct support for critical early-stage activities.
Northpond Builds facilitates introductions to investor networks to support further investment in emerging companies.
Northpond Builds establishes preferred vendor relationships to support the operational needs of emerging companies.
Portfolio
Engineering cell lines to address critical challenges in gene therapy manufacturing.
#R&D Tools
Makes handheld and desktop mass spectrometry devices to enable lab analysis wherever and whenever it’s needed.
#R&D Tools
Combines advances in protein engineering, nucleic acid chemistry, and disease gene biology to achieve cell-specific oligonucleotide delivery.
#Biotechnology
Pioneering the field of upregulation to restore healthy gene expression in diseased cells by programmable modulation of a new class of RNA called regRNA.
#Biotechnology
Developing oncolytic viral immunotherapies for the treatment of high unmet need cancers such as prostate and glioblastoma.
#Biotechnology
Expands the number of samples a lab can process when using the same equipment and lab technicians, without sacrificing accuracy.
#Diagnostics
Key People
Founder & CEO
Co-Founder, Partner
Partner
Chief Financial Officer, Partner
Operating Partner